Table 6. Obstetric and neonatal outcomes for pregnant women admitted to an intensive care unit with severe acute respiratory syndrome coronavirus 2, France*.
| ID | Prenatal corticosteroid, GA, wk, d† | Prenatal magnesium sulfate, GA, wk, d† | Time from diagnosis to delivery, d | Mode of delivery | GA at birth, wk, d | Birthweight, g (z-score) | 5-min Apgar score | Umbilical arterial pH | Neonatal intubation | NICU |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NA | 29 | 2 | Cesarean | 29 | 1,400 (1.10) | 7 | 7.26 | Y | Y |
| 2 | NA | NA | 8 | Cesarean | 39, 1 | 3,290 (0.06) | 10 | 7.21 | N | N |
| 3 | 30, 1 | 30+1 | 11 | Cesarean | 30, 2 | 1,500 (0.75) | 8 | 7.25 | Y | Y |
| 4 | 26, 4 | 26+4 | 7 | Cesarean | 27, 1 | 1,010 (0.82) | 1 | 7.28 | Y | Y |
| 5 | 26, 1 | 26, 4 | 7 | Cesarean | 27, 6 | 890 (−0.83) | 3 | 7.24 | Y | Y |
| 6 | NA | NA | 1 | Cesarean | 40, 6 | 3,570 (0.18) | 3 | ND | N | N |
| 7 | NA | 23, 5 | Ongoing pregnancy | NA | NA | NA | NA | NA | NA | NA |
| 8 | NA | 29, 4 | Ongoing pregnancy | NA | NA | NA | NA | NA | NA | NA |
| 9 | NA | NA | 1 | Cesarean | 36, 1 | 2,940 (0.49) | 10 | ND | N | N |
| 10 | 26, 6 | 27, 1 | 3 | Cesarean | 27, 2 | 1,065 (1.12) | 10 | 7.27 | Y | Y |
*All neonates tested negative for SARS-CoV-2. GA, gestational age; NA, not applicable; ND, not done; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †At time of drug administration.